
Startup Nome Aims to Accelerate Rare Disease Drug Development Using AI
Jacalyn Lee, founder of The DAND Alliance, is partnering with the startup Nome to develop treatments for her daughter's rare genetic disorder. Nome uses AI to provide research roadmaps and project management for families facing ultra-rare conditions.












